Ā | Control Group (nĀ =ā129) | E-pathway Group (nĀ =ā52) | Unadjusted | Adjusteda | ||
---|---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |||
Primary Outcomes | ||||||
āDelay in surgery (>ā48āh), n (%) | 77 (59.7%) | 11 (21.6%) | 0.19 (0.09ā0.39) | <ā0.001 | 0.22 (0.10ā0.49) | <ā0.001 |
āLOS, median (IQR) | 12 (7ā19) | 11 (7ā17) | ā1.12 (ā4.41ā2.18)b | 0.505 | ā1.07 (ā4.77ā2.62)b | 0.567 |
Secondary Outcomes | ||||||
āIn-hospital Mortality, n (%) | 7 (5.4%) | 1 (1.9%) | 0.34 (0.04ā2.85) | 0.321 | 0.19 (0.01ā2.49) | 0.206 |
Discharge Location, n (%) | ||||||
āHome | 11 (8.5%) | 6 (11.5%) | 1.40 (0.49ā4.00) | 0.531 | 1.52 (0.40ā5.73) | 0.539 |
āNursing Home/RAC | 32 (24.8%) | 9 (17.3%) | 0.63 (0.28ā1.44) | 0.278 | 0.67 (0.27ā1.67) | 0.393 |